At a glance
- In the one placebo-controlled trial (164 women), venlafaxine beat placebo on PMDD symptom scores, with 43% reaching remission versus 25% on placebo.
- Venlafaxine is an SNRI: it raises serotonin and norepinephrine, unlike SSRIs, which raise serotonin alone.
- Trials used venlafaxine two ways: taken daily, or taken only in the two weeks before a period, with the dose set by a doctor.
- Reported side effects were mild and usually temporary: nausea, insomnia, and dizziness.
- A doctor decides the dose and whether to take it daily or only before a period, based on her history and other medicines.
Strength of evidence
Moderate evidence
One placebo-controlled RCT (n=164) found venlafaxine reduced PMDD symptoms significantly more than placebo, and a small open-label trial (n=12) in women who hadn't responded to placebo found a similar benefit, with fast response and mostly mild side effects in both. There's no meta-analysis and no second large RCT yet, so the evidence is real but thinner than the data behind SSRIs.
Does venlafaxine work for PMDD?
Yes, for many women it does. In the one placebo-controlled trial of venlafaxine in PMDD, a 2001 study in Obstetrics & Gynecology with 164 women, those taking venlafaxine had significantly larger drops in symptom scores than those on placebo. Symptom remission happened in 43% of the venlafaxine group versus 25% on placebo.
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). Most PMDD trials test SSRIs, which raise serotonin alone. Venlafaxine raises both serotonin and norepinephrine, which may be part of why it helps some women who haven't responded to an SSRI.
If your main symptoms are PMS rather than full PMDD, the picture is similar but not identical: see venlafaxine for PMS.
The improvement showed up fast in that trial: most of the drop in symptoms happened in the first treatment cycle, not after months of daily use.
Venlafaxine isn't usually a first choice. SSRIs have more trial data behind them for PMDD. Venlafaxine tends to come up when an SSRI hasn't worked well enough, or caused side effects a woman couldn't tolerate.
What does the research say?
Two trials have tested venlafaxine for PMDD directly. Both are small by modern standards, but both found a real effect.
| Study | What they measured | What they found |
|---|---|---|
| 2001 RCT, continuous dosing, 164 women | Daily symptom scores over 4 cycles | Scores dropped significantly more than placebo; improvement was fastest in cycle 1 |
| 2001 RCT, continuous dosing, 164 women | Remission (symptoms back to post-period levels) | 43% remission on venlafaxine versus 25% on placebo |
| 2004 trial, luteal-only dosing, 12 women | Response over 2 cycles of luteal-only dosing | 9 of 11 women (82%) had a satisfactory response |
Neither trial has been repeated at a larger scale, and there's no meta-analysis pooling venlafaxine PMDD trials the way there is for some SSRIs. That's why the evidence here counts as moderate, not strong: a real signal, but from a small evidence base.
How do you take venlafaxine for PMDD?
Trials have used venlafaxine two different ways: every day, or only before a period.
- Continuous dosing: taken daily, with the dose adjusted over the first few cycles based on how she responds and any side effects, as decided by a doctor.
- Luteal-phase-only dosing: taken for roughly the two weeks before a period, at a dose and schedule a doctor sets.
The luteal-only pattern, tested in a small 2004 trial, meant women took venlafaxine for roughly two weeks a month instead of year-round.
Which pattern fits depends on how regular her cycle is, how early symptoms start, and whether stopping an SSRI or SNRI suddenly has caused problems for her before. Venlafaxine can cause discontinuation symptoms if stopped abruptly, so a doctor decides the dose, the schedule, and how to stop it safely.
How long does it take to work?
In the 2001 trial, improvement came fast: most of the drop in symptom scores happened in the first treatment cycle, not gradually over months. By the fourth cycle, most responders had settled at a stable, lower symptom level.
In the smaller 2004 trial using luteal-only dosing, response was assessed after two cycles, and 82% of the women who completed it had a satisfactory response by then.
That's different from how venlafaxine is often used for depression, where it can take four to six weeks to show its full effect. For PMDD, because doses are often compared against a woman's own earlier cycles, a clearer signal can show up within one or two cycles.
If nothing has changed after two full cycles of consistent use, that's worth raising with whoever prescribed it. It may mean a dose change, a different timing, or a different medicine.
What are the side effects?
The two PMDD trials reported mostly mild, short-lived side effects:
- Nausea
- Insomnia
- Dizziness
These eased for most women as treatment continued and weren't severe enough to make many women stop.
Venlafaxine can also raise blood pressure, especially at higher doses, so a doctor usually checks it before starting and during treatment. Stopping suddenly can bring on discontinuation symptoms, like irritability, dizziness, or flu-like feelings, which is part of why the smaller trial tracked how women felt between cycles when they came off it.
If side effects feel worse than the PMDD symptoms venlafaxine is meant to help with, that's a reason to go back to whoever prescribed it rather than stopping on your own.
Who should avoid it?
These trials don't tell us about venlafaxine's effects in pregnancy, breastfeeding, or alongside medicines like MAOIs, since that wasn't their focus.
In general, venlafaxine needs extra caution, or isn't used, if a woman:
- Is pregnant or trying to become pregnant
- Has uncontrolled high blood pressure
- Takes an MAOI or certain other serotonergic medicines
- Has a history of mania or bipolar disorder, since antidepressants can occasionally trigger a manic episode
It's also worth checking the pattern first. If mood symptoms are present most of the month and just worsen before a period, that's premenstrual exacerbation of an existing condition, not premenstrual dysphoric disorder (PMDD), and the underlying condition usually needs its own treatment too.
A doctor who knows her full history, medicines, and cycle pattern is the one to decide if venlafaxine is safe to start.
What else helps alongside it?
Medicine isn't the only piece. Guidelines also point to:
- Cognitive behavioral therapy (CBT), which can reduce PMDD symptoms and is sometimes combined with medicine
- Daily symptom tracking, so you and a doctor can see the real pattern rather than guessing
- Basic sleep and movement habits, which don't treat PMDD but can make the days before your period more manageable
Tracking matters more than it sounds like it would. A DRSP chart kept for two cycles often turns "I think it's worse before my period" into something a doctor can act on, and it's the same kind of tool used to diagnose PMDD in the trials above.
For the moment itself, when a fight or a wave of rage is already happening, medicine won't help fast enough. Niyora is a PMS and PMDD support app. Its Moon feature lets you write down what happened, see it from another angle, and draft a reply you can sit on for 20 minutes before sending anything.
If venlafaxine hasn't brought things under control, finding a PMDD specialist is a good next step. For a wider view of what's proven to help, see PMDD treatment: what actually helps.
Questions people ask
Does Effexor work for PMDD?+
Yes, in the main placebo-controlled trial, Effexor (venlafaxine) reduced PMDD symptom scores significantly more than placebo, with 43% of women reaching full remission compared with 25% on placebo. A smaller trial using luteal-only dosing found a similar benefit, though neither trial has been repeated at a larger scale.
What is the Effexor dose for PMDD?+
Trials have tested venlafaxine both taken daily and taken only in the two weeks before a period. The exact dose and schedule depend on her history and response, and a doctor sets both.
What do Effexor for PMDD reviews say?+
There isn't a published collection of Effexor for PMDD reviews, only clinical trial data. In those trials, most women who responded noticed a difference within one or two cycles, and side effects like nausea and dizziness were usually mild, though individual experience still varies.
Is venlafaxine an SSRI or SNRI?+
Venlafaxine is an SNRI, a serotonin-norepinephrine reuptake inhibitor, not an SSRI. It raises both serotonin and norepinephrine, while SSRIs like sertraline and fluoxetine raise serotonin alone. That difference may be part of why venlafaxine sometimes helps when an SSRI hasn't, though the trials didn't specifically test women who'd already tried an SSRI.
When should I see a doctor about PMDD?+
If PMDD symptoms take up a week of every month, or you have thoughts of hurting yourself, see a GP or gynecologist and bring two months of daily symptom notes. That pattern, tracked daily, is how PMDD gets properly diagnosed and how a doctor judges whether venlafaxine or another option fits.
Sources
- 1.Venlafaxine in the treatment of premenstrual dysphoric disorder, Obstetrics and gynecology, 2001
- 2.Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder, Journal of clinical psychopharmacology, 2004